Grünenthal and Rosa to present at the 2018 SID/IID dermatology meeting

Dr. Katherine Kudrycki, Principal Scientist at Rosa & Co, will present "Evaluation of a novel therapy and identification of uncertainties critical to efficacy and competitive differentiation in a Psoriasis PhysioPD™ Platform. " at the 2018 SID/IID Dermatology meeting in Orlando, FL May 16-19, 2018.

Together with Grünenthal, Rosa & Co developed a Psoriasis QSP model to mechanistically represent the physiology of a single chronic psoriatic plaque (including keratinocytes, immune cells, cytokines and chemokines and their regulation), drug PK and clinical outcomes (e.g., PASI score). At the meeting Dr. Kudrycki will demonstrate how the model was qualified and used to get insights into the therapeutic potential and efficacy of novel small molecule enzyme-specific inhibitors.

For more information, contact Dr. Katherine Kudrycki at kkudrycki@rosaandco.com

To download/watch webinars and stay informed about upcoming webinars, please fill out and submit your information.

Note that this information will not be provided in any form to any third parties.

You now have access to past Rosa's Worldwide Webinars. 

Each session includes a presentation and short discussion and lasts about 1 hour

Looks like there is an issue with the sign in form. Contact us directly and we'll look into the issue.  webinar@rosaandco.com

Complete the form below and receive monthly alerts on "Impact of Modeling & Simulation in Drug Development" webinars and QSP news.

Note that this information will not be provided in any form to any third parties.

You are now subscribed.

Looks like there is an issue with the mailing list subscription form. Contact us directly and we'll look into the issue.  webinar@rosaandco.com